33 related articles for article (PubMed ID: 21884787)
1. Developing an in vitro lipolysis model for real-time analysis of drug concentrations during digestion of lipid-based formulations.
Ejskjær L; O'Dwyer PJ; Ryan CD; Holm R; Kuentz M; Box KJ; Griffin BT
Eur J Pharm Sci; 2024 Mar; 194():106681. PubMed ID: 38128839
[TBL] [Abstract][Full Text] [Related]
2. There is plenty of room in protein-RNA condensates.
Yu M; Lemke EA
Biophys J; 2021 Apr; 120(7):1121-1122. PubMed ID: 33691085
[No Abstract] [Full Text] [Related]
3. The Precipitation Behavior of Poorly Water-Soluble Drugs with an Emphasis on the Digestion of Lipid Based Formulations.
Khan J; Rades T; Boyd B
Pharm Res; 2016 Mar; 33(3):548-62. PubMed ID: 26597939
[TBL] [Abstract][Full Text] [Related]
4. Toward the establishment of standardized in vitro tests for lipid-based formulations, part 3: understanding supersaturation versus precipitation potential during the in vitro digestion of type I, II, IIIA, IIIB and IV lipid-based formulations.
Williams HD; Sassene P; Kleberg K; Calderone M; Igonin A; Jule E; Vertommen J; Blundell R; Benameur H; Müllertz A; Pouton CW; Porter CJ;
Pharm Res; 2013 Dec; 30(12):3059-76. PubMed ID: 23661145
[TBL] [Abstract][Full Text] [Related]
5. Insights into drug precipitation kinetics during in vitro digestion of a lipid-based drug delivery system using in-line raman spectroscopy and mathematical modeling.
Stillhart C; Imanidis G; Kuentz M
Pharm Res; 2013 Dec; 30(12):3114-30. PubMed ID: 23456098
[TBL] [Abstract][Full Text] [Related]
6. Enhancing intestinal drug solubilisation using lipid-based delivery systems.
Porter CJ; Pouton CW; Cuine JF; Charman WN
Adv Drug Deliv Rev; 2008 Mar; 60(6):673-91. PubMed ID: 18155801
[TBL] [Abstract][Full Text] [Related]
7. In vitro digestion kinetics of excipients for lipid-based drug delivery and introduction of a relative lipolysis half life.
Arnold YE; Imanidis G; Kuentz M
Drug Dev Ind Pharm; 2012 Oct; 38(10):1262-9. PubMed ID: 22206451
[TBL] [Abstract][Full Text] [Related]
8. Solubilisation of poorly water-soluble drugs during in vitro lipolysis of medium- and long-chain triacylglycerols.
Christensen JØ; Schultz K; Mollgaard B; Kristensen HG; Mullertz A
Eur J Pharm Sci; 2004 Nov; 23(3):287-96. PubMed ID: 15489130
[TBL] [Abstract][Full Text] [Related]
9. Chain length affects pancreatic lipase activity and the extent and pH-time profile of triglyceride lipolysis.
Benito-Gallo P; Franceschetto A; Wong JC; Marlow M; Zann V; Scholes P; Gershkovich P
Eur J Pharm Biopharm; 2015 Jun; 93():353-62. PubMed ID: 25936853
[TBL] [Abstract][Full Text] [Related]
10. Controlled poorly soluble drug release from solid self-microemulsifying formulations with high viscosity hydroxypropylmethylcellulose.
Yi T; Wan J; Xu H; Yang X
Eur J Pharm Sci; 2008 Aug; 34(4-5):274-80. PubMed ID: 18541418
[TBL] [Abstract][Full Text] [Related]
11. Study of drug concentration effects on in vitro lipolysis kinetics in medium-chain triglycerides by considering oil viscosity and surface tension.
Arnold YE; Imanidis G; Kuentz M
Eur J Pharm Sci; 2011 Oct; 44(3):351-8. PubMed ID: 21884787
[TBL] [Abstract][Full Text] [Related]
12. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
Dahan A; Hoffman A
J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
